Events

Apollo Therapeutics will be attending the upcoming Imperial Collider, hosted by Imperial College London: Health – Innovations for Partners, People & Populations.

CEO, Richard Mason, will be speaking on the panel “Biomedical sector landscape and key trends,” exploring the current biopharma landscape, including key trends, challenges, and opportunities shaping innovation and investment.

VP, Head of Research Partnerships, Kay Penicud, will be speaking on the panel “Partnering that works: identifying science and building collaboration,” focusing on how successful partnerships are built and how high-potential science is translated into real-world impact.

At Apollo Therapeutics we match our world-class industrial drug discovery and drug development capabilities with basic medical breakthroughs made at our top university partners to create important new medicines.

We look forward to engaging with peers and collaborators at the event.